Y-mAbs Therapeutics, Inc. (YMAB) by event type
YMAB moves most on coverage initiations — a median of +1.07% at 30 minutes across 15 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the YMAB overview →
How YMAB reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 1,295 of 2,603 | 20 | 0.00% | 65% | +0.12% |
| Coverage initiations 138 of 2,283 | 15 | +1.07% | 60% | -3.92% |
| Rating reiterations 1,583 of 3,522 | 40 | 0.00% | 53% | +0.44% |
| Price-target cuts 73 of 1,527 | 10 | +0.41% | 80% | +3.71% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how YMAB usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target cuts → · YMAB overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GSRX INDUSTRIES INC (GSRX) | 226 | 0.00% | 19% |
| TETRALOGIC PHARMS CORP (TLOG) | 226 | +0.20% | 52% |
| Aurinia Pharmaceuticals Inc - Common Shares (AUPH) | 224 | +0.13% | 54% |
| Cel-Sci Corporation (CVM) | 224 | -0.54% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.